Saturday, March 22, 2008
Sorry I have been away for a while.
The first tune I heard today was this young lady. Hasn't she grown up nicely. A good home grown, English girl who traveled to the US and made it big time. Anyway.....
Estelle featuring Kanye West - American Boy

Its just one of those tunes you can't get out your head once its in. I just had to infect any readers here. Its a good thing that I have a small collection of massive rock to fall back on eh!

Lets break you back in to reality with this eh.
My Iron Lung Acoustic

And my god this:
Tool - Jambi - Morgasmo

Thank god for rock eh. What would I do without it?

I spilt a cup of boiling water on my leg when making a cup of coffee and burnt my leg...Badly. I have a burn which is two inches long on my right thigh. It been without dressing or pants for a week. I have it dressed now and it healing nicely. I felt like a fool sitting with one leg naked and this popped blister that looked scary. We live and learn eh.

MRI results back in for my spine.... Neuro wants a head one as spine shows no increase on scaring plague in two years since last one. The words used were no progression in two years. I don't qualify for Tysabri treatment without it. The disablement has changed for sure, in my eyes but I am no neuro. We wait with baited breath.

Stay well,
posted by personallog! @ 6:48 am  
  • At 7:10 pm, Anonymous Anonymous said…

    To hear from a doc "No progression in disease (no increase in scarring plaques)from last MRI" is what we all want to hear. Glad you had a good report of the spine MRI.

    Maybe the brain MRI will answer your questions about disablement. Sorry to read about the burn - I've done that alot too - except that I can't feel the burn due to the numbness. I hope it is not too painful for you.

    Take care, Anne

  • At 7:37 pm, Blogger AlecDroz said…


    The results of a new survey of people living with MS and care providers were announced today by the National Multiple Sclerosis Society and by Acorda Therapeutics. A press release announcing the results appears below. I am sending this information to you in the hope that you might find these new statistics about MS of interest for your blog. If you know of any other bloggers who might find this of interest I also hope you will share it with them.

    In many cases the results are not surprising, though they do provide confirmation of some widely help opinions among people living with MS. Fully two-thirds of people with MS report difficulty walking and many find that walking difficulties affect their quality of life and their ability to work. But the study also presents some new findings related to mobility. Nearly 40% of people with MS and 50% of their care partners report that they rarely, if ever, discuss mobility issues with a physician. Almost 47% of MS patients report that difficulty walking has increased the cost of their care. And although 92% of people with MS report that use a mobility device (wheelchair, scooter) and say it is "worth it," 45% of people with MS report that they are or would be embarrassed by using a mobility device. These findings could have important implications in helping people with MS who experience difficulty walking and other mobility issues in the years ahead.

    If you would like any additional details regarding this study, please feel free to contact me. I hope you find this information of interest.

    Alec Drozdowski
    Tel: 212-253-8881
    Fax: 212-253-8241

    Loss of Mobility Found to Impact Quality of Life and Emotional and Financial Health of Most People Living with Multiple Sclerosis
    Tuesday March 25, 10:00 am ET

    Two new complementary surveys provide groundbreaking data on the impact of walking impairment on people living with multiple sclerosis, revealing challenges related to quality of life, family relationships, independence, work, financial security and other areas

    NEW YORK & HAWTHORNE, N.Y.--(BUSINESS WIRE)--The symptoms of multiple sclerosis (MS) that affect mobility have a significant impact on quality of life, safety, and financial and emotional health among many people living with MS, according to the results of two 2008 surveys conducted by Harris Interactive on behalf of Acorda Therapeutics, Inc. and the National MS Society. The findings, gathered from interviews conducted among representative samples of 1011 people living with MS and 317 care partners, provide new data related to the impact of mobility loss and walking difficulty on different aspects of daily life for people with MS.

    Among people with MS surveyed, almost two-thirds (64%) experience trouble walking, the inability to walk or loss of balance at least twice each week. Of those people with MS who report trouble walking, 94% find it at least somewhat disruptive to their overall daily life, with 63% finding it very disruptive or disruptive. Fully 70% of people with MS who have difficulty walking* report it to be the most challenging aspect of their MS. Despite these findings, 39% of the people with MS and 49% of the care partners who were surveyed report that they rarely or never discuss mobility issues with a physician.

    “Among the many important conclusions we can draw from these studies is that they indicate we must educate more people with MS and care partners about the impact of mobility loss and the options now available to address mobility challenges,” said Dr. Nicholas LaRocca, vice president, health care delivery and policy research, National MS Society.

    The studies also found that fatigue is a very common symptom of MS. Among people with MS, 76% indicate that they experience fatigue at least twice each week. Of those, 95% report that fatigue is at least somewhat disruptive in their daily lives, with 60% reporting that fatigue is either “disruptive” or “very disruptive.” Fatigue is also known to have an impact on mobility and balance for many people living with MS.

    “Many people do not realize the extent to which symptoms such as fatigue can affect people living with MS. Physical fatigue is a very common symptom of MS that can also affect mobility and balance. This study clearly demonstrates that it is essential to assess the impact of multiple symptoms in MS in order to develop effective educational programs and treatment strategies,” observed Dr. LaRocca.

    Fear of mobility loss is a major concern among people when they are first diagnosed with MS. The surveys found two of the most commonly cited concerns among people with MS when they are first diagnosed are restrictions on daily activity (78%) and the diminished ability to work (76%). Other findings include:


    A majority of people living with MS think that walking problems

    due to MS have some or a great deal of negative impact on:


    the ability to carry out daily tasks, such as shopping or going to the bank (70%);


    self esteem (69%); and


    the ability to travel (66%).


    58%of people with MS who have difficulty walking say it caused

    them to miss common, significant life events, including 22% who

    missed a wedding and 26% who cancelled vacation plans.


    Of people with MS who have difficulty walking:


    74% report that family members had to take on more household

    responsibilities because of difficulty walking;


    68% find that getting around can be dangerous due to difficulty walking; and


    47% find that difficulty walking has increased the cost of their care.

    In addition to exploring the impact of diverse MS symptoms on the lives of people with MS and on care partners, the surveys also examined the tools that people with MS are using to deal with difficulty walking:

    86% of the people with MS who use a mobility device report they do so to maintain their independence and 54% because of frequent falls;
    92% of people with MS who use a mobility device report that using a mobility device is “worth it,” though 45% of people with MS report that they are or would be embarrassed about using a mobility device; and
    36% of people with MS who use a mobility device report that they do not use a mobility device as much as they should.
    “These surveys provide important new insights about how walking disability affects the quality of life of people with MS, their families and other care partners. Examining walking disability from different perspectives can help provide a better understanding of its prevalence and impact. These findings, coupled with previous research on aspects of walking impairment such as the use of assistive devices, highlight the need to continue to develop new treatment options,” said Andrew Blight, Ph.D., chief scientific officer of Acorda Therapeutics.

    Mobility challenges are also found to have a profound impact on the careers and financial health of many people with MS and care partners:

    Among people with MS who are employed and who experience difficulty walking, 44% have had to take days off from work and 34% have had to work reduced hours because of difficulty walking.
    Fully 50% of people with MS who experience difficulty walking report that their living expenses have increased either a little (32%) or a lot (18%) as a result of mobility issues.
    Among care partners who are employed, 46% report their work has been negatively impacted, including 32% who have had to take days off as a result of their care giving responsibilities.
    “As someone who has lived with MS for over two decades now, I see that people with MS are living fuller and more active lives than ever before, but we clearly have a long way to go. For me, MS and especially mobility issues have had a direct impact on my ability to work and the cost of my care. These surveys shed new light on the challenges that thousands of us with MS are experiencing every day,” said Mimi Mosher, a patient advocate from Mechanicsville, VA, and a person living with MS who uses both a scooter and a wheelchair.

    The full results of the surveys will be presented at a special media briefing hosted by the National MS Society on April 8 in New York City. The surveys were sponsored by Acorda Therapeutics in collaboration with the National MS Society.

    *In this survey, mobility or difficulty walking was defined as having trouble walking or the inability to walk two or more times per week.

    About the Study

    The two surveys were conducted online within the United States by Harris Interactive of behalf of Acorda Therapeutics and the National MS Society between January 28 and February 25, 2008 including one survey among 1011 U.S. adults who had been diagnosed with multiple sclerosis and a separate survey among 317 U.S. adults who are currently somewhat or very involved with caring for a family member or friend with multiple sclerosis. No estimates of theoretical sampling error can be calculated; a full methodology is available upon request.

    About Multiple Sclerosis

    Multiple sclerosis interrupts the flow of information between the brain and the body and stops people from moving. Every hour in the United States, someone is newly diagnosed with MS, an unpredictable, often disabling disease of the central nervous system. Symptoms range from reduced or lost mobility to numbness and tingling to blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with more than twice as many women as men being diagnosed with the disease. MS affects more than 400,000 people in the U.S. and 2.5 million worldwide.

    About the National MS Society

    MS stops people from moving. The National MS Society exists to make sure it doesn’t. We help each person address the challenges of living with MS. In 2006 alone, through our home office and our 50 state network of chapters, we devoted nearly $126 million to programs that enhanced more than one million lives to move us closer to a world free of MS. The Society also invested more than $46 million to support 440 research projects around the world. We are people who want to do something about MS NOW. Join the movement at

    About Acorda Therapeutics, Inc.

    Acorda Therapeutics, Inc. (NASDAQ: ACOR - News) is a biotechnology company developing therapies for spinal cord injury, multiple sclerosis and related nervous system disorders. For more information, please go to

    About Harris Interactive®

    Harris Interactive is a global leader in custom market research. With a long and rich history in multimodal research, powered by our science and technology, we assist clients in achieving business results. Harris Interactive serves clients globally through our North American, European and Asian offices and a network of independent market research firms. For more information, please visit

  • At 7:27 am, Blogger Jaime said…


    I am so glad to hear of the results. No new lesions in the spine is great news. I am keeping my fingers crossed that you will have good news for your brain MRI as well.

    Having said that, my neuro has very clearly stated that the MRI does not show everything (many MS'ers have what they call invisable damage which is why we sometimes have symptoms that don't show on the MRI). She says that how your MS is doing is based on a combination of what you see on the MRI and what your body is doing. MS is so up and down and can change from day to day. I wish there was something easy we could do to make it all go away, but for now, just hang in there and hopefully your doc can give you some answers.

    Take care and keep in touch. It's been a while. Miss you!


Post a comment
<< Home
ms....not just a diary
About Me

Name: personallog!
Home: St. Annes, Lancashire, United Kingdom
About Me:
I am 6ft 3" skinny and not well. I was diagnosed with ms in 2004 and I would like to speak with others who have ms. I have a want to raise money for ms charities. We have to find a cure for this hell!!!! See my complete profile

More of ME
ms/disabilty reads
Other Interests
Previous Post